Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M

Opexa Therapeutics reports 2019 executive compensation

By ExecPay News

Published: October 14, 2020

Opexa Therapeutics reported fiscal year 2019 executive compensation information on October 14, 2020.
In 2019, three executives at Opexa Therapeutics received on average a compensation package of $1.1M, a 129% increase compared to previous year.
Average pay of disclosed executives at Opexa Therapeutics
Chris Schelling, Chief Executive Officer, received $1.5M in total, which increased by 167% compared to 2018. 70.28% of Schelling's compensation, or $1M, was in option awards. Schelling also received $436K in salary.
William T. Andrews, M.D., FACP, Chief Medical Officer, received a compensation package of $1.1M, which increased by 115% compared to previous year. 42.53% of the compensation package, or $462K, was in option awards.
Harry Palmin, Chief Financial Officer, earned $844.4K in 2019, a 97% increase compared to previous year.

Related executives

Chris Schelling

Opexa Therapeutics

Chief Executive Officer

William FACP

Opexa Therapeutics

Chief Medical Officer

Harry Palmin

Opexa Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on October 14, 2020.